
Enable job alerts via email!
Generate a tailored resume in minutes
Land an interview and earn more. Learn more
A leading global biopharma company in Singapore is seeking a Data & Analytics Senior Risk Manager to drive innovative analytics solutions for risk detection. The ideal candidate will leverage deep technical expertise to create impactful data-driven tools and communicate effectively with business leaders across a diverse, international environment. This role demands a strong quantitative background, experience in analytics, and exceptional leadership skills.
The Risk Analytics and Monitoring (RAM) team supports GSK in establishing a proactive, data-driven compliance culture that aligns with the organization's strategic objectives and core values. Our team delivers actionable insights to the Legal and Compliance function, enabling the company to anticipate, prioritize, and manage risks across key activities. Through advanced analytics, we highlight emerging trends and exposures, equipping Compliance to meet evolving regulatory challenges. By promoting data-driven decisions, we strengthen risk management and drive continuous improvement, positioning Compliance as a strategic asset within GSK.
The Data & Analytics Senior Risk Manager is responsible for identifying, designing, and delivering advanced analytics solutions to address emerging risk. This role combines strong technical skills with business understanding to guide decisions, lead solution delivery, and take ownership of key analytic products.
This position also requires significant interpersonal and communication skills in addition to deep technical expertise. The ideal candidate works effectively across cultural and functional boundaries, partnering with business areas and countries in an international, matrixed environment. Leadership capability is essential, as you will inspire change rather than command action.
Uniting science, technology and talent to get ahead of disease together.
GSK is a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive. We get ahead of disease by preventing and treating it with innovation in specialty medicines and vaccines. We focus on four therapeutic areas: respiratory, immunology and inflammation; oncology; HIV; and infectious diseases – to impact health at scale.
People and patients around the world count on the medicines and vaccines we make, so we’re committed to creating an environment where our people can thrive and focus on what matters most. Our culture of being ambitious for patients, accountable for impact and doing the right thing is the foundation for how, together, we deliver for patients, shareholders and our people.